2Mc Gregor D, Shand B, Lynn K. A controlled trial of the effect of folate supplements on homocysteine, lipids and hemorheology in end-stage renal disease. Nephron, 2000, 85(3) :215--20.
3Koren E, Conter C, Mueller G , et el. Triglyceride enriched lipoprotein particles correlate with the severity of coronary artery disease. Atherosclerosis, 1996,122 : 105-107.
4Amadottir M, Thysell H, Nilsso-Ehle P. Serumlipoprotein (a) concentration is increased in moderate renal failure. Nephron. 1996.72:712-715.
5Verzola A,Perini L,Gattos,et al. Causes and risks of hyperlipidemia during dialysis and after renal transplantation [J]. Recenti Prog Med,1998;89:590-597.
6Koren E, Corder C, Mueller G, et al. Triglyceride enriched lipoprotein particles correlate with the severty of coronary artery disease [J]. Atherosclerosis, 1996 ; 122 : 105-107.
7Clee SM, Zhang H, Bissada N, et al. Relationship between lipoprotein lipase and high density lipoprotein cholesterol in mice:Modulation by cholesteryl ester transfer protein and dietary status[J]. J Lipid Res, 1997 ; 38:2079-2089.
8KimSB, Yang WS, Kang ES, et al. Lipoprotein(a) and apolipopretein (a) phenotypes in patients with end-stage renal disease [J]. Perit Dial Int, 1997 ; 17: 236-242.
9Amadottir M, Thysell H, Nilsso-Ehle P. Serum lipoprotein(a)concerntrtion is increased in moderate renal failure [J]. Nephron,1996;72:712-715.
10Kronenberg F, Konig P, Neyer U, et al. Multicenter study of lipoprotein(a) and apolipoprotein (a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis [ J]. J Am Soc Nephrol, 1995 ; 6:110-120.
